QQ客服 官方微博 反馈留言

	Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)
	Hu C.S., Chan A., Gao L., Ahn M.-J., Cohen E., Ang M.-K., Cheng Y., Hu Q., Kim S.-B., Li P., Sun Y., Fan B., Cheng G., Ehrnrooth E., Wang C.-H.
刊名	Annals of Oncology
	2015
ISSN号	0923-7534
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4867892
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Hu C.S., Chan A., Gao L., Ahn M.-J., Cohen E., Ang M.-K., Cheng Y., Hu Q., Kim S.-B., Li P., Sun Y., Fan B., Cheng G., Ehrnrooth E., Wang C.-H.. Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)[J]. Annals of Oncology,2015.
APA	Hu C.S., Chan A., Gao L., Ahn M.-J., Cohen E., Ang M.-K., Cheng Y., Hu Q., Kim S.-B., Li P., Sun Y., Fan B., Cheng G., Ehrnrooth E., Wang C.-H..(2015).Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4).Annals of Oncology.
MLA	Hu C.S., Chan A., Gao L., Ahn M.-J., Cohen E., Ang M.-K., Cheng Y., Hu Q., Kim S.-B., Li P., Sun Y., Fan B., Cheng G., Ehrnrooth E., Wang C.-H.."Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)".Annals of Oncology (2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。